Related references
Note: Only part of the references are listed.Distribution of Transplantation-Associated Thrombotic Microangiopathy (TA-TMA) and Comparison between Renal TA-TMA and Intestinal TA-TMA: Autopsy Study
Rin Yamada et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy
Narendranath Epperla et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host disease in gastrointestinal biopsies
Michelle Anna Ehmann et al.
BONE MARROW TRANSPLANTATION (2020)
Vascular endothelial syndromes after HCT: 2020 update
Enric Carreras et al.
BONE MARROW TRANSPLANTATION (2020)
Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy
M. E. Martinez-Munoz et al.
BONE MARROW TRANSPLANTATION (2019)
Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience
Sarah Sartain et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
Christopher C. Dvorak et al.
FRONTIERS IN PEDIATRICS (2019)
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
Anand Padmanabhan et al.
JOURNAL OF CLINICAL APHERESIS (2019)
Plasmic and Plasic Are Excellent Predictors of Severe ADAMTS13 Deficiency in Thrombotic Microangiopathy Patients without Secondary Causes
Eleni Gavriilaki et al.
BLOOD (2019)
Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease
Eleni Gavriilaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT
Ivan S. Moiseev et al.
BONE MARROW TRANSPLANTATION (2019)
Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions
Simona Pagliuca et al.
BLOOD ADVANCES (2019)
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation
Merve Postalcioglu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)
K. L. Winthrop et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients
Joslyn Rudoni et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Complement in Pathophysiology and Treatment of Transplant -Associated Thrombotic Microangiopathies
Sonata Jodele
SEMINARS IN HEMATOLOGY (2018)
Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation
Eleni Gavriilaki et al.
CLINICAL TRANSPLANTATION (2018)
Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies
J. Khosla et al.
BONE MARROW TRANSPLANTATION (2018)
Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy
Narendranath Epperla et al.
TRANSFUSION (2017)
Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional Therapy
Stephan R. Bohl et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy
Mikako Warren et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation
Jiaqian Qi et al.
ANNALS OF HEMATOLOGY (2017)
Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD
Nicholas J. Gloude et al.
BLOOD (2017)
Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy
Gianluigi Ardissino et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation
L. Yeates et al.
BONE MARROW TRANSPLANTATION (2017)
Early Results of Phase II Study Using OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HCT-TMA)
Samer K. Khaled et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
Sonata Jodele et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy
S. Vasu et al.
BONE MARROW TRANSPLANTATION (2016)
Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series
Brian T. Brinkerhoff et al.
MODERN PATHOLOGY (2016)
New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Sonata Jodele et al.
TRANSFUSION AND APHERESIS SCIENCE (2016)
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease
Paloma Garcia-Martin et al.
ANNALS OF PHARMACOTHERAPY (2015)
Abnormal Echocardiography 7 Days after Stem Cell Transplantation May Be an Early Indicator of Thrombotic Microangiopathy
Christopher E. Dandoy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation
Javier El-Bietar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
Sonata Jodele et al.
BLOOD REVIEWS (2015)
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy
K. Balassa et al.
BONE MARROW TRANSPLANTATION (2015)
Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC
Flore Sicre de Fontbrune et al.
TRANSPLANTATION (2015)
Estimated versus Measured Glomerular Filtration Rate in Children before Hematopoietic Cell Transplantation
Benjamin L. Laskin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
Sonata Jodele et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Sonata Jodele et al.
BLOOD (2014)
Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease
S. Hingorani et al.
BONE MARROW TRANSPLANTATION (2014)
Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy
D. Lerner et al.
BONE MARROW TRANSPLANTATION (2014)
Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis
Sepideh Shayani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Pulmonary Hypertension after Hematopoietic Stem Cell Transplantation
Christopher E. Dandoy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
Sonata Jodele et al.
TRANSFUSION (2013)
Renal Arteriolar C4d Deposition: A Novel Characteristic of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
Benjamin L. Laskin et al.
TRANSPLANTATION (2013)
The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura
Marie-Luise John et al.
ANNALS OF HEMATOLOGY (2012)
Cystatin C-estimated Glomerular Filtration Rate in Pediatric Autologous Hematopoietic Stem Cell Transplantation
Benjamin L. Laskin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation
Sonata Jodele et al.
PEDIATRIC TRANSPLANTATION (2012)
Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Benjamin L. Laskin et al.
BLOOD (2011)
Large pericardial effusion as a complication in adults undergoing SCT
M. Norkin et al.
BONE MARROW TRANSPLANTATION (2011)
Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT
B. L. Laskin et al.
BONE MARROW TRANSPLANTATION (2011)
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
Yasunobu Ishikawa et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Transplant-associated Thrombotic Microangiopathy in Pediatric Patients Treated With Sirolimus and Tacrolimus
Joseph Rosenthal et al.
PEDIATRIC BLOOD & CANCER (2011)
Plasmapheresis-Refractory Thrombotic Microangiopathy in a Hematopoietic Stem Cell Transplant Recipient
Radovan Vasko et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient
R. Lopes da Silva et al.
TRANSPLANT INFECTIOUS DISEASE (2011)
The Role of Endothelial Cell Injury in Thrombotic Microangiopathy
Ryan J. Goldberg et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Chronic Kidney Disease, Thrombotic Microangiopathy, and Hypertension Following T Cell-Depleted Hematopoietic Stem Cell Transplantation
Ilya G. Glezerman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens
Roberto Rodriguez et al.
BLOOD (2010)
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning
E. Willems et al.
BONE MARROW TRANSPLANTATION (2010)
Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation
H. Cohen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link
M. Scully et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians
P. Coppo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation
Byung-Sik Cho et al.
TRANSPLANTATION (2010)
Nitric oxide in transplantation-related thrombotic microangiopathy
J. Thachil
BONE MARROW TRANSPLANTATION (2009)
Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy
Y. Inamoto et al.
BONE MARROW TRANSPLANTATION (2009)
Renal Thrombotic Microangiopathy after Hematopoietic Cell Transplant: Role of GVHD in Pathogenesis
Siribha Changsirikulchai et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation Diagnosis and Treatment
Cecilia M. Choi et al.
DRUGS (2009)
Thrombotic Microangiopathy During Peripheral Blood Stem Cell Mobilization
Harris V. N. Naina et al.
JOURNAL OF CLINICAL APHERESIS (2009)
Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria
Glen A. Kennedy et al.
TRANSFUSION (2009)
Vascular endothelium and graft-versus-host disease
Barbara C. Biedermann
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Albuminuria in Hematopoietic Cell Transplantation Patients: Prevalence, Clinical Associations, and Impact on Survival
Sangeeta R. Hingorani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura
A. M. Carella et al.
BONE MARROW TRANSPLANTATION (2008)
Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
B-S Cho et al.
BONE MARROW TRANSPLANTATION (2008)
Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
E. D. Batts et al.
BONE MARROW TRANSPLANTATION (2007)
Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab
Wing-Yan Au et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient
M. Ostronoff et al.
BONE MARROW TRANSPLANTATION (2007)
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: Risk factors and response to treatment
Betul Oran et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group
Tapani Ruutu et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Spectrum of renal pathology in hematopoietic cell transplantation: A series of 20 patients and review of the literature
Anthony Chang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab
Elisa Gallerani et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
Cornelio Uderzo et al.
TRANSPLANTATION (2006)
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease
D. Wolff et al.
BONE MARROW TRANSPLANTATION (2006)
Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation
F. Peyvandi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation
Hirohisa Nakamae et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Defibrotide, a polydisperse mixture of single-stranded phosphodiester oligonucleotides with lifesaving activity in severe hepatic veno-occlusive disease: Clinical outcomes and potential mechanisms of action
N Kornblum et al.
OLIGONUCLEOTIDES (2006)
Hemolytic uremic syndrome after bone marrow transplantation: Clinical characteristics and outcome in children
GA Hale et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation
VT Ho et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Creatinine production, nutrition, and glomerular filtration rate estimation
S Beddhu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Clinical significance of fragmented red cells after allogeneic bone marrow transplantation
H Kanamori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome
H Takatsuka et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
